Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Dr. Nasser Al-Rashid Research Chair in Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Acta Ophthalmol. 2019 Feb;97(1):e122-e128. doi: 10.1111/aos.13835. Epub 2018 Sep 21.
To determine the concentrations of the CC chemokines CCL2, CCL7, CCL8, CCL11, CCL13, CCL20, CCL24 and CCL26 in aqueous humour (AH) samples from patients with specific uveitic entities.
Aqueous humour samples from patients with active uveitis associated with Behçet's disease (BD) (n = 13), sarcoidosis (n = 8), HLA-B27-related inflammation (n = 12), Vogt-Koyanagi-Harada (VKH) disease (n = 12) and control patients (n = 9) were assayed with the use of a multiplex assay.
When considering all uveitis patients as one group, all chemokine levels except CCL2 were significantly increased compared to controls. CCL8, CCL13 and CCL20 were the most strongly upregulated, 48-fold, 118-fold and 173-fold, respectively, above control AH levels. CCL8 and CCL13 levels were significantly higher in HLA-B27-associated uveitis than in sarcoidosis and VKH disease. CCL20 levels were significantly higher in HLA-B27-associated uveitis than in BD, sarcoidosis and VKH disease. In addition, CCL20 levels were significantly higher in BD than in VKH disease. In HLA-B27-associated uveitis, CCL8, CCL13 and CCL20 were upregulated 111-fold, 255-fold and 465-fold, respectively, compared with controls. CCL8, CCL13 and CCL20 levels were significantly higher in nongranulomatous uveitis (BD and HLA-B27-associated uveitis) than in granulomatous uveitis (sarcoidosis and VKH disease).
Immune responses mediated by CCL8, CCL13 and CCL20 appear to be more potent in nongranulomatous uveitis, particularly in HLA-B27-associated uveitis.
确定特定葡萄膜炎患者房水中 CC 趋化因子 CCL2、CCL7、CCL8、CCL11、CCL13、CCL20、CCL24 和 CCL26 的浓度。
使用多重分析检测活动期与 Behçet 病(BD)(n=13)、结节病(n=8)、HLA-B27 相关炎症(n=12)、Vogt-Koyanagi-Harada(VKH)病(n=12)和对照患者(n=9)相关的葡萄膜炎患者的房水样本。
当将所有葡萄膜炎患者视为一组时,除 CCL2 外,所有趋化因子水平均明显高于对照组。CCL8、CCL13 和 CCL20 的上调最为明显,分别是对照房水中的 48 倍、118 倍和 173 倍。HLA-B27 相关葡萄膜炎患者的 CCL8 和 CCL13 水平明显高于结节病和 VKH 病患者。HLA-B27 相关葡萄膜炎患者的 CCL20 水平明显高于 BD、结节病和 VKH 病患者。此外,BD 患者的 CCL20 水平明显高于 VKH 病患者。在 HLA-B27 相关葡萄膜炎中,CCL8、CCL13 和 CCL20 分别上调了 111 倍、255 倍和 465 倍。非肉芽肿性葡萄膜炎(BD 和 HLA-B27 相关葡萄膜炎)患者的 CCL8、CCL13 和 CCL20 水平明显高于肉芽肿性葡萄膜炎(结节病和 VKH 病)患者。
CCL8、CCL13 和 CCL20 介导的免疫反应在非肉芽肿性葡萄膜炎中似乎更为强烈,特别是在 HLA-B27 相关葡萄膜炎中。